Literature DB >> 19001088

Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells.

Vladimir L Gabai1, Julia A Yaglom, Todd Waldman, Michael Y Sherman.   

Abstract

The heat shock protein Hsp72 is expressed at the elevated levels in various human tumors, and its levels often correlate with poor prognosis. Previously we reported that knockdown of Hsp72 in certain cancer cells, but not in untransformed breast epithelial cells, triggers senescence via p53-dependent and p53-independent mechanisms. Here we demonstrate that the p53-dependent pathway controlled by Hsp72 depends on the oncogenic form of phosphatidylinositol 3-kinase (PI3K). Indeed, upon expression of the oncogenic PI3K, epithelial cells began responding to Hsp72 depletion by activating the p53 pathway. Moreover, in cancer cell lines, activation of the p53 pathway caused by depletion of Hsp72 was dependent on oncogenes that activate the PI3K pathway. On the other hand, the p53-independent senescence pathway controlled by Hsp72 was associated with the Ras oncogene. In this pathway, extracellular signal-regulated kinases (ERKs) were critical for senescence, and Hsp72 controlled the ERK-activating kinase cascade at the level of Raf-1. Importantly, upon Ras expression, untransformed cells started responding to knockdown of Hsp72 by constitutive activation of ERKs, culminating in senescence. Therefore, Hsp72 is intimately involved in suppression of at least two separate senescence signaling pathways that are regulated by distinct oncogenes in transformed cells, which explains why cancer cells become "addicted" to this heat shock protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001088      PMCID: PMC2612502          DOI: 10.1128/MCB.01041-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

Review 1.  Premature senescence of endothelial cells: Methusaleh's dilemma.

Authors:  Jun Chen; Michael S Goligorsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05       Impact factor: 4.733

2.  Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

Authors:  Ogechi N Ikediobi; Helen Davies; Graham Bignell; Sarah Edkins; Claire Stevens; Sarah O'Meara; Thomas Santarius; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathan Hinton; Chris Hunter; Andy Jenkinson; David Jones; Vivienne Kosmidou; Richard Lugg; Andrew Menzies; Tatiana Mironenko; Adrian Parker; Janet Perry; Keiran Raine; David Richardson; Rebecca Shepherd; Alex Small; Raffaella Smith; Helen Solomon; Philip Stephens; Jon Teague; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; William Reinhold; John N Weinstein; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal:  Mol Cancer Ther       Date:  2006-11-06       Impact factor: 6.261

3.  Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA.

Authors:  Jung-Sik Kim; Carolyn Lee; Challice L Bonifant; Habtom Ressom; Todd Waldman
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

4.  Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides.

Authors:  Sunil C Kaul; Satoshi Aida; Tomoko Yaguchi; Kamaljit Kaur; Renu Wadhwa
Journal:  J Biol Chem       Date:  2005-09-21       Impact factor: 5.157

5.  Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway.

Authors:  Christophe Denoyelle; George Abou-Rjaily; Vladimir Bezrookove; Monique Verhaegen; Timothy M Johnson; Douglas R Fullen; Jenny N Pointer; Stephen B Gruber; Lyndon D Su; Mikhail A Nikiforov; Randal J Kaufman; Boris C Bastian; Maria S Soengas
Journal:  Nat Cell Biol       Date:  2006-09-10       Impact factor: 28.824

6.  Dissecting the senescence-like program in tumor cells activated by Ras signaling.

Authors:  Teeru Bihani; Agustin Chicas; Crystal Pui-Kwan Lo; Athena W Lin
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

7.  High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways.

Authors:  Julia A Yaglom; Vladimir L Gabai; Michael Y Sherman
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

8.  Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells.

Authors:  B Karakas; A Weeraratna; A Abukhdeir; B G Blair; H Konishi; S Arena; K Becker; W Wood; P Argani; A M De Marzo; K E Bachman; B H Park
Journal:  Oncogene       Date:  2006-04-17       Impact factor: 9.867

Review 9.  Oncogene-induced senescence: putting the brakes on tumor development.

Authors:  Melanie Braig; Clemens A Schmitt
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

10.  Inactivation of dual-specificity phosphatases is involved in the regulation of extracellular signal-regulated kinases by heat shock and hsp72.

Authors:  Julia Yaglom; Cornelia O'Callaghan-Sunol; Vladimir Gabai; Michael Y Sherman
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

View more
  58 in total

1.  Cancer-linked satellite 2 DNA hypomethylation does not regulate Sat2 non-coding RNA expression and is initiated by heat shock pathway activation.

Authors:  Gaëlle Tilman; Nausica Arnoult; Sandrine Lenglez; Amandine Van Beneden; Axelle Loriot; Charles De Smet; Anabelle Decottignies
Journal:  Epigenetics       Date:  2012-06-22       Impact factor: 4.528

2.  Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence.

Authors:  Nadine Martin; Moussa Benhamed; Karim Nacerddine; Maud D Demarque; Maarten van Lohuizen; Anne Dejean; Oliver Bischof
Journal:  EMBO J       Date:  2011-10-14       Impact factor: 11.598

Review 3.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

4.  HSP90 and HSP70 proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein.

Authors:  Yong Teng; Lambert Ngoka; Yun Mei; Leslieann Lesoon; John K Cowell
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

5.  Facilitating Akt clearance via manipulation of Hsp70 activity and levels.

Authors:  John Koren; Umesh K Jinwal; Ying Jin; John O'Leary; Jeff R Jones; Amelia G Johnson; Laura J Blair; Jose F Abisambra; Lyra Chang; Yoshinari Miyata; Anna M Cheng; Jianping Guo; Jin Q Cheng; Jason E Gestwicki; Chad A Dickey
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

6.  Triptolide reduces the viability of osteosarcoma cells by reducing MKP-1 and Hsp70 expression.

Authors:  Lei Zhao; B O Jiang; Dong Wang; Wei Liu; Huawu Zhang; Weisheng Liu; Zhen Qiu
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

7.  The Molecular Chaperone Heat Shock Protein 70 Controls Liver Cancer Initiation and Progression by Regulating Adaptive DNA Damage and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling Pathways.

Authors:  Wonkyoung Cho; Xiongjie Jin; Junfeng Pang; Yan Wang; Nahid F Mivechi; Demetrius Moskophidis
Journal:  Mol Cell Biol       Date:  2019-04-16       Impact factor: 4.272

Review 8.  The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.

Authors:  Kristoffer R Brandvold; Richard I Morimoto
Journal:  J Mol Biol       Date:  2015-05-21       Impact factor: 5.469

9.  Allosteric landscapes of eukaryotic cytoplasmic Hsp70s are shaped by evolutionary tuning of key interfaces.

Authors:  Wenli Meng; Eugenia M Clerico; Natalie McArthur; Lila M Gierasch
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-05       Impact factor: 11.205

10.  Hsp70-Bag3 interactions regulate cancer-related signaling networks.

Authors:  Teresa A Colvin; Vladimir L Gabai; Jianlin Gong; Stuart K Calderwood; Hu Li; Suryaram Gummuluru; Olga N Matchuk; Svetlana G Smirnova; Nina V Orlova; Irina A Zamulaeva; Mikel Garcia-Marcos; Xiaokai Li; Z T Young; Jennifer N Rauch; Jason E Gestwicki; Shinichi Takayama; Michael Y Sherman
Journal:  Cancer Res       Date:  2014-07-03       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.